about
Malnutrition in systemic sclerosisReview article: the assessment and management of chronic severe gastrointestinal dysmotility in adultsCD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection.Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy.Non-nutritive sweeteners: no class effect on the glycaemic or appetite responses to ingested glucoseMapping glucose-mediated gut-to-brain signalling pathways in humans.Adaptive immunity alters distinct host feeding pathways during nematode induced inflammation, a novel mechanism in parasite expulsion.The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome.Genetic analysis of the Trichuris muris-induced model of colitis reveals QTL overlap and a novel gene cluster for establishing colonic inflammationSweetness and bitterness taste of meals per se does not mediate gastric emptying in humans.Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis.Colonic transcriptional profiling in resistance and susceptibility to trichuriasis: phenotyping a chronic colitis and lessons for iatrogenic helminthosis.Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease.The mycotoxin patulin, modulates tight junctions in caco-2 cells.Ochratoxin A displaces claudins from detergent resistant membrane microdomains.Mouse GPR40 heterologously expressed in Xenopus oocytes is activated by short-, medium-, and long-chain fatty acids.Ochratoxin A increases permeability through tight junctions by removal of specific claudin isoforms.Multiple fatty acid sensing mechanisms operate in enteroendocrine cells: novel evidence for direct mobilization of stored calcium by cytosolic fatty acid.Gastrin regulates the heparin-binding epidermal-like growth factor promoter via a PKC/EGFR-dependent mechanism.Immune control of food intake: enteroendocrine cells are regulated by CD4+ T lymphocytes during small intestinal inflammation.Gastric emptying of hexose sugars: role of osmolality, molecular structure and the CCK₁ receptor.Conveying medication benefits to ulcerative colitis patients and effects on patient attitudes regarding thresholds for adherence.Better disease specific patient knowledge is associated with greater anxiety in inflammatory bowel disease.Cholecystokinin pathways modulate sensations induced by gastric distension in humans.Enterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environments.One size fits all? Choosing the right format to convey statistical information.Functional neuroimaging demonstrates that ghrelin inhibits the central nervous system response to ingested lipid.Crohn's disease affecting the small bowel is associated with reduced appetite and elevated levels of circulating gut peptides.Colestyramine slows gastric emptying of liquids and reduces appetite in healthy subjects.Patients' knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool ('CCPKnow').Enteroendocrine cells in terminal ileal Crohn's disease.Short-term dietary supplementation with fructose accelerates gastric emptying of a fructose but not a glucose solution.GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrierBarrett's oesophagus: A qualitative study of patient burden, care delivery experience and follow-up needsFatty acid chain length determines cholecystokinin secretion and effect on human gastric motilityPlasma cholecystokinin concentrations are elevated in acute upper gastrointestinal infectionsPlasma chromogranin A in patients with inflammatory bowel disease: a possible explanationCommentary: a comparison of glucagon-like peptides 1 and 2Duodenal CCK cells from male mice express multiple hormones including ghrelinInflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views
P50
Q27025667-EEC81B90-5762-468C-BE86-3DDC4C742547Q27030666-0D7B9824-67BB-490C-82E7-9EDD5AB431C6Q33274027-CB044968-E0B6-468D-8694-62618115DCC8Q33457440-44EE5C75-831A-4524-AAF3-1A1B7A1E7FD8Q33577923-94871FD8-0878-442D-82B9-1C02B727CD7AQ33822337-C94D8459-675C-4BC7-9A9B-0E90E006F766Q34561893-93879274-689D-4422-8FDC-8565608F2004Q36407290-2C37E91C-8630-4066-9D2F-351E02E22F54Q36752889-9A545EE6-A0AD-4BDB-BC9E-B5176868084DQ37337560-EED23E32-DE9D-4CAC-870D-467C5A1CE428Q38265308-2BB79628-8703-45E3-82CD-8414148020DDQ38505504-7DA9349B-713F-4F7E-8CD4-4021AD4E9DB5Q39375492-837DD2E0-204B-456D-A011-910C55AEBAFCQ39915862-222DD10F-D4B0-4018-BA3D-457D02EDA2B3Q40133503-D4ADC8E6-2717-423E-9ECC-F407723CCFE3Q40355212-2321127E-49D0-4984-965B-F96743B2BA89Q40540029-865E47F5-0CED-47C7-91EA-818A9B2EBBDBQ40569788-69D06B16-72FC-44FE-B697-1DCE296A36F7Q40592305-BF86341E-2AAC-44B1-A5AF-CC3EDC1933E6Q42844712-EAEAD23F-BAAD-4E28-91BF-46B37116D011Q43003157-C74A3F60-1E3F-4979-94D2-29737299AB6BQ43764999-07ABB41B-E358-4058-BA81-7A709B47E73BQ44516622-8DADC20C-EB3B-4D13-A93F-E43E760C8E5CQ44756872-05D29B0B-7C74-40C0-91FC-D47CA655DAB6Q46806151-DC93C6AC-0A01-4A24-85EC-2B3E6E864ACCQ47577118-935C6D60-582B-4F11-AAB6-795C55E419E4Q48010731-A6CE21A9-54DB-4E86-AC6C-2A426666119FQ48367625-C5F4CAFA-5D5E-4622-B252-0F56D6F49938Q48419593-A3EBDEC3-0636-47AB-B59D-B2079EB4F438Q48445390-58A20EFD-53F3-4654-B7A0-28C648508125Q48625003-186C2506-AF5E-48C7-A540-255AD6B7FE93Q51693370-1ACE9E87-E878-43AE-A9DD-D03EBEF2926BQ60042081-1CB44C49-DC60-4E3F-AF3E-2C4934ED80ECQ60062796-0E7B66DC-ECBF-43D7-84A7-BED875652A72Q77738379-458BD232-F9A3-4FDF-B354-0B1DA19F2D14Q79181158-5308DA4B-BB83-46A7-ABD5-CA9539C422B0Q84568054-6E646274-AEAA-4A14-8CC4-9481C541524EQ85735474-516E0E93-D6C0-4CE5-8BFA-BD46DBC1B7C5Q87366981-E3A176A0-C425-4B0A-A300-B3A6C476CD71Q87414154-528701B5-8414-4484-847D-FE8025778B96
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
John Mclaughlin
@ast
John Mclaughlin
@en
John Mclaughlin
@es
John Mclaughlin
@nl
John Mclaughlin
@sl
type
label
John Mclaughlin
@ast
John Mclaughlin
@en
John Mclaughlin
@es
John Mclaughlin
@nl
John Mclaughlin
@sl
prefLabel
John Mclaughlin
@ast
John Mclaughlin
@en
John Mclaughlin
@es
John Mclaughlin
@nl
John Mclaughlin
@sl
P106
P1153
37097173600
P21
P31
P496
0000-0001-6158-5135